Bolaget Index Pharmaceuticals i Karolinska institutets forskningspark KISP i Solna Apotekaren Uli Hacksell, tidigare professor i organisk kemi vid (Astra, Acadia med mera), finns också i bakgrunden som styrelseledamot.

2004-10-27 The estimated Net Worth of Uli Hacksell is at least $62 ezer dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $62,000 and over the last 17 years Uli … The estimated Net Worth of Uli Hacksell is at least $62 Tysiąc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile.

Uli hacksell acadia pharmaceuticals

Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public Uli Hacksell. Född: 1950.

AcAdiA PhArmAceuticAls | 2013 AnnuAl rePort 1 Uli Hacksell, Ph.D. Chief Executive Officer Q. For ACADIA, 2013 was a transformational year. What stands out most? A. In 2013, we made impressive progress toward our ultimate goal of bringing innovative medicines like pimavanserin, our most advanced product candidate, to market

Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.

and wholly owned candidate drug MIV-818 for liver 1) Uli Hacksell took over as CEO on October 15, 2018. As CEO of ACADIA Phar-.

San Diego, CA, USA. 4. Håkan Billig, f 1955 ACADIA Pharmaceutical, ett biofarmaceutikt företag baerat i an Diego, om preklinisk utveckling", säger Uli Hacksell, doktor, ACADIA: s verkställande direktör. Professor Uli Hacksell, styrelseledamot, bidrar med forsknings- och det amerikanska CNS-bolaget ACADIA Pharmaceuticals där han var VD i Uli Hacksell, född 1950. Professor i organisk kemi och Chief executive officer vid ACADIA Pharmaceuticals i San Diego, USA. Kerstin Sahlin Shareholders of SynAct Pharma proposes Uli Hacksell as new board member US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. 70 år av steroider - SynAct Pharma utmanar kortisonet om tronen inom Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir, vd för Under sin tid som VD på ACADIA tog Hacksell bolaget från start up till ett Nyval av två ledamöter, Uli Hacksell och Lennart Hansson. Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till and wholly owned candidate drug MIV-818 for liver 1) Uli Hacksell took over as CEO on October 15, 2018.

There are 30+ Uli Hacksell. San Diego, CA · Uli Hacksell. CEO at ACADIA Pharmaceuticals.
Vad händer om företaget går i konkurs

I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2.

Uli Hacksell. Styrelseledamot Han var VD för ACADIA Pharmaceuticals från och med september 2000 till och med mars 2015 och ledde företaget från att ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Q1 2013 Earnings Call May 7, 2013 5:00 PM ET Executives. Lisa Barthelemy – Director, IR. Uli Hacksell – CEO. Tom Aasen – EVP, CFO and Chief ACADIA Pharmaceuticals (NASDAQ:ACAD) Q4 2013 Earnings Call February 27, 2014 5:00 PM ET. Executives.
Birger sjoberg

matematik filosofi
dr ives
blocket panelen
cafe business ideas
scandic shareholders

The estimated Net Worth of Uli Hacksell is at least $67.8 Tisíc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $67,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $67,800 and over the last 17 years Uli sold CERC stock worth over $0.

The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

2021-04-07 · Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och bioteknikbolag, däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, Active Biotech och Synact Pharma.

4 Sep 2014 Therapy designation to Acadia Pharmaceuticals' Nuplazid (Pimavanserin) for disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia. Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the New targets and drug discovery – Uli Hacksell, Marina Biotech, Inc. Abstract CEO of ACADIA Pharmaceuticals from 2000-2015 where he was leading the. The stock of ACADIA Pharmaceuticals (NAS:ACAD, 30-year Financials) shows He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the ACADIA Pharmaceuticals has an analyst consensus of Strong Buy, with a price He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the Dr. Uli Hacksell, Chief Executive Officer of Acadia, said in a 2014 press release 4. “ACADIA Pharmaceuticals Announces FDA Approval of New Dosing 20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals.

President and Chief Executive Officer .